Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused pentacyclic imidazole derivatives as modulators of TNF activity

Fused pentacyclic imidazole derivatives as modulators of TNF activity

US Patent 10953019 · Granted Mar 23, 2021

Estimated economic value: $21,242,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydrobenzo-quinoline sulfonamides derivative compounds2025
Pyrrolidinone derivatives as formyl peptide 2 receptor agonists2025
Thiophene derivatives for the treatment of disorders caused by IgE2024
Fused pentacyclic imidazole derivatives2024
Fused pentacyclic imidazole derivatives2024
Fused pentacyclic imidazole derivatives2024
Fused pentacyclic imidazole derivatives2024
Fused pentacyclic imidazole derivatives as modulators of TNF activity2023
Antimalarial hexahydropyrimidine analogues2022
Fused imidazole derivatives as IL-17 modulators2022
Spirocyclic indane analogues as IL-17 modulators2022
Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors2021